Navigation Links
An IRB Barcelona project on computational biology receives an ERC Advanced Grant
Date:10/27/2011

The European Research Council (ERC) has awarded Modesto Orozco, researcher at the Institute for Research in Biomedicine (IRB Barcelona), an Advanced Grant within the category of Physical Sciences and Engineering, which received 917 applications from around Europe. This category commonly accounts for 45% of the total budget dedicated to Advanced Grants, which provide project funding typically in the range of between 2 and 3 million Euros over five years. These ERC grants have been operating since 2007 and aim to support internationally recognized scientists performing cutting-edge research in Europe. The projects awarded are characterized by having a strong multidisciplinary nature and innovative applications in emerging fields.

Modesto Orozco, brief CV

Dr. Modesto Orozco heads the Molecular Modelling and Bioinformatics group at IRB Barcelona. He is a senior professor in Biochemistry and Molecular Biology at the University of Barcelona, director of the Life Sciences Department at the Barcelona Supercomputing Center (BSC), director of the Joint IRB Barcelona/BSC Computational Biology Programme, and director of the Structural Biology node of the Instituto Nacional de Bioinformtica (INB).

Dr. Orozco is a European leader in the simulation of biological systems and an international authority in the theoretical study of macromolecular systems, especially nucleic acids (DNA and RNA). During his career he has published more than 300 scientific articles and developed a series of computational programmes and algorithms that are used by the scientific community worldwide. His articles have received about 9,000 citations with an elevated impact factor, as reflected by a Hirsch index of 51, thus positioning him as one of the most visible chemists and computational biologists in the world. Dr. Orozco is an editor and editorial member of the most prestigious international scientific journals in his field of expertise. He has also served or is serving on several evaluation panels in Spain, Europe and the United States and he is an external consultant to a number of pharmaceutical companies. Dr. Orozco's research has been awarded various national and international prizes and receives funding from the Marcelino Botn Foundation.

The SimDNA project

The full name of Dr. Orozco's project is "Advanced multiscale simulation of DNA". SimDNA comprises three parts: the development of theoretical models and algorithms for computational simulations at several scales of resolution; the implementation of computational programmes; and the experimental validation of the predictions. The objective is to provide information about the structure and physical properties of nucleic acids and how these features explain the function of these molecules. Through SimDNA, the international scientific community will be provided with a series of computational tools that will unravel the behaviour of nucleic acids. The most direct application is in the field gene expression regulation and in epigenetics. In other words, the tools developed in the SimDNA project will allow scientists to fully understand the mechanisms that control gene expression.


'/>"/>
Contact: Snia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Related biology news :

1. Amber MD Workshop 2011 -- May 3-6, Barcelona
2. Scientists at IRB Barcelona discover a new protein critical for mitochondria
3. Universitat Autonoma de Barcelona researchers first to clone mice in Spain
4. IRB Barcelona to coordinate two European projects on biomedicine
5. Researchers at IRB Barcelona produce more data on key genes in diabetes
6. Barcelona Declaration 2008: Challenges and Pathways to Earth Sustainability
7. Eurofins MWG Operon and Integrated Genomics cooperate to provide complete genome projects
8. Eurofins MWG Operon and Integrated Genomics cooperate to provide complete genomics projects
9. $3.6 million nursing research project promotes exercise for girls
10. TGen graduate students receive $50,000 each from Salt River Projects support program
11. $40 million project to revitalize Africas orphaned crops announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
An IRB Barcelona project on computational biology receives an ERC Advanced Grant
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: